Review



rabbit anti abca1 pab  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals rabbit anti abca1 pab
    Rabbit Anti Abca1 Pab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 387 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti abca1 pab/product/Novus Biologicals
    Average 94 stars, based on 387 article reviews
    rabbit anti abca1 pab - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    96
    Proteintech rabbit anti abca1
    Rabbit Anti Abca1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti abca1/product/Proteintech
    Average 96 stars, based on 1 article reviews
    rabbit anti abca1 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc abca1
    Abca1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abca1/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    abca1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti abca1 antibody
    Anti Abca1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti abca1 antibody/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    anti abca1 antibody - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    Novus Biologicals rabbit anti abca1 pab
    Rabbit Anti Abca1 Pab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti abca1 pab/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    rabbit anti abca1 pab - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit anti abca1 mab
    ( A ) Enhancement of growth inhibitory effect of NC on human renal carcinoma cells by co-treatment with an <t>ABCA1</t> inhibitor cyclosporin A (CsA). Cells were grown with or without 20 μM NC and 10 μM CsA for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC. Results are shown as mean of at least four independent experiments ± SD (Tukey–Kramer’s multiple comparison test). n = 4 (KMRC-3,786-O,A498), 5 (Caki-1) or 6 (TUHR14TKB). ( B–E ) Immunoblot analysis of whole-cell lysate of human renal carcinoma cell lines. A representative result from three independent experiments is shown ( B ). Quantitative analyses of Snail ( C ) and ABCA1 ( D ) expression are presented. A scatter plot illustrating the correlation between ABCA1 and Snail expression levels is also shown ( E ). Quantitative data are shown as mean of three independent experiments ± SD (Tukey–Kramer’s test). ( F ) Comparison of ABCA1 expression between normal tissue and primary tumor of indicated subtypes of renal cancers analyzed using UCSC Xena ( https://xenabrowser.net/ ). Bars indicate means (Welch’s t- test). ( G ) Immunohistochemistry of a surgically extracted renal tissue from a patient with Fuhrman grade 3 primary ccRCC, indicating upregulation of ABCA1 in the lesion site. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissue . Scale bars, 250 μm (left), 50 μm (right). ( H ) Quantification of ABCA1 signal from surgically extracted renal tissues from three patients for each Fuhrman grade (Tukey–Kramer’s test; see also ). ( I ) Phase-contrast images of EpH4 wild-type cells (top) and Snail-overexpression cells (bottom, EpH4-Snail). Scale bars, 50 μm. ( J ) Immunofluorescence images of EpH4 and EpH4-Snail cells. The cells were fixed. Scale bars, 20 μm. ( K ) Acquisition of NC resistance by exogenous expression of Snail in EpH4 cells and enhancement of 20 μM NC effect on EpH4-Snail cells by co-treatment with 10 μM CsA. Data are presented as in ( A ) ( n = 3, Tukey–Kramer’s test). ( L ) Immunoblot analyses of whole-cell lysates of EpH4, EpH4-Snail, E-cadherin KO, and α-catenin KO EpH4 cells. Quantitative analyses of ABCA1 expression is also shown ( n = 3, Dunnett”s test). ( M ) Immunofluorescence images of EpH4 and EpH4-Snail cells. Cells were fixed with MeOH. Scale bars, 20 μm. ( N, O ) Immunoblot analyses of whole-cell lysates of MDCK II cells ( N ) expressing KRAS G12V treated with 5 μg/ml TGFβ for 0, 3, and 8 days and human esophageal carcinoma cell lines TE-15 and TE-8 ( O ). Graphs on the bottom show analyses from three biological replicates (Tukey–Kramer’s test [ N ] and Student’s t -test [ O ]). Phase-contrast images are also shown on the top ( O ). Scale bars, 50 μm. Figure 1—source data 1. Original raw data for the immunoblot images shown in . Figure 1—source data 2. Labeled full blot images for the immunoblot images shown in .
    Rabbit Anti Abca1 Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti abca1 mab/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit anti abca1 mab - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc abca 1 e7x5g rabbit mab
    ( A ) Enhancement of growth inhibitory effect of NC on human renal carcinoma cells by co-treatment with an <t>ABCA1</t> inhibitor cyclosporin A (CsA). Cells were grown with or without 20 μM NC and 10 μM CsA for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC. Results are shown as mean of at least four independent experiments ± SD (Tukey–Kramer’s multiple comparison test). n = 4 (KMRC-3,786-O,A498), 5 (Caki-1) or 6 (TUHR14TKB). ( B–E ) Immunoblot analysis of whole-cell lysate of human renal carcinoma cell lines. A representative result from three independent experiments is shown ( B ). Quantitative analyses of Snail ( C ) and ABCA1 ( D ) expression are presented. A scatter plot illustrating the correlation between ABCA1 and Snail expression levels is also shown ( E ). Quantitative data are shown as mean of three independent experiments ± SD (Tukey–Kramer’s test). ( F ) Comparison of ABCA1 expression between normal tissue and primary tumor of indicated subtypes of renal cancers analyzed using UCSC Xena ( https://xenabrowser.net/ ). Bars indicate means (Welch’s t- test). ( G ) Immunohistochemistry of a surgically extracted renal tissue from a patient with Fuhrman grade 3 primary ccRCC, indicating upregulation of ABCA1 in the lesion site. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissue . Scale bars, 250 μm (left), 50 μm (right). ( H ) Quantification of ABCA1 signal from surgically extracted renal tissues from three patients for each Fuhrman grade (Tukey–Kramer’s test; see also ). ( I ) Phase-contrast images of EpH4 wild-type cells (top) and Snail-overexpression cells (bottom, EpH4-Snail). Scale bars, 50 μm. ( J ) Immunofluorescence images of EpH4 and EpH4-Snail cells. The cells were fixed. Scale bars, 20 μm. ( K ) Acquisition of NC resistance by exogenous expression of Snail in EpH4 cells and enhancement of 20 μM NC effect on EpH4-Snail cells by co-treatment with 10 μM CsA. Data are presented as in ( A ) ( n = 3, Tukey–Kramer’s test). ( L ) Immunoblot analyses of whole-cell lysates of EpH4, EpH4-Snail, E-cadherin KO, and α-catenin KO EpH4 cells. Quantitative analyses of ABCA1 expression is also shown ( n = 3, Dunnett”s test). ( M ) Immunofluorescence images of EpH4 and EpH4-Snail cells. Cells were fixed with MeOH. Scale bars, 20 μm. ( N, O ) Immunoblot analyses of whole-cell lysates of MDCK II cells ( N ) expressing KRAS G12V treated with 5 μg/ml TGFβ for 0, 3, and 8 days and human esophageal carcinoma cell lines TE-15 and TE-8 ( O ). Graphs on the bottom show analyses from three biological replicates (Tukey–Kramer’s test [ N ] and Student’s t -test [ O ]). Phase-contrast images are also shown on the top ( O ). Scale bars, 50 μm. Figure 1—source data 1. Original raw data for the immunoblot images shown in . Figure 1—source data 2. Labeled full blot images for the immunoblot images shown in .
    Abca 1 E7x5g Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abca 1 e7x5g rabbit mab/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    abca 1 e7x5g rabbit mab - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc monoclonal anti abca1 antibody
    Treg exp increase <t>ABCA1</t> expression by transferring cAMP into M IL4 . (A) Changes in the expression of ABCA1 and ABCG1 transcripts in M IL4 co-cultured with either Teffs or Treg exp . Gene expression quantified by qRT-PCR comparing mRNA levels in M IL4 alone (RQ = 1, shown as dashed line) with the same cells co-cultured for 4h with either Teffs or Tregs. UBC was used as reference gene. (B) Intracellular concentration of cAMP in Tregs exp alone, M IL4 alone, or M IL4 co-cultured with Tregs exp for 4h. cAMP levels were normalized to total cellular protein content. Statistical analysis was performed only between M IL4 and M IL4 + Tregs exp , as the aim was to assess whether cAMP levels in M IL4 increase upon co-culture. The cAMP level in Tregs exp is shown as a reference to highlight the high concentration of this molecule in these cells but was not included in the statistical comparison due to the difference in cell type. (C) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Treg exp (ratio 1:1) after 1h preincubation or not with GAP27 (300 µM). (D) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Tregs (ratio 1:1) after 1h preincubation or not with PKA inhibitor H89 (5 µM). (E) Western blot analysis of <t>ABCA1</t> <t>protein</t> level in cell lysates of M IL4 alone or M IL4 co-cultured (ratio 1:1) with either Treg exp or Teff for 4h. Data were plotted as ABCA1 protein intensity normalised to GAPDH protein intensity. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison test. *p<0.05, **p<0.01.
    Monoclonal Anti Abca1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monoclonal anti abca1 antibody/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    monoclonal anti abca1 antibody - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit anti abca1
    Treg exp increase <t>ABCA1</t> expression by transferring cAMP into M IL4 . (A) Changes in the expression of ABCA1 and ABCG1 transcripts in M IL4 co-cultured with either Teffs or Treg exp . Gene expression quantified by qRT-PCR comparing mRNA levels in M IL4 alone (RQ = 1, shown as dashed line) with the same cells co-cultured for 4h with either Teffs or Tregs. UBC was used as reference gene. (B) Intracellular concentration of cAMP in Tregs exp alone, M IL4 alone, or M IL4 co-cultured with Tregs exp for 4h. cAMP levels were normalized to total cellular protein content. Statistical analysis was performed only between M IL4 and M IL4 + Tregs exp , as the aim was to assess whether cAMP levels in M IL4 increase upon co-culture. The cAMP level in Tregs exp is shown as a reference to highlight the high concentration of this molecule in these cells but was not included in the statistical comparison due to the difference in cell type. (C) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Treg exp (ratio 1:1) after 1h preincubation or not with GAP27 (300 µM). (D) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Tregs (ratio 1:1) after 1h preincubation or not with PKA inhibitor H89 (5 µM). (E) Western blot analysis of <t>ABCA1</t> <t>protein</t> level in cell lysates of M IL4 alone or M IL4 co-cultured (ratio 1:1) with either Treg exp or Teff for 4h. Data were plotted as ABCA1 protein intensity normalised to GAPDH protein intensity. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison test. *p<0.05, **p<0.01.
    Rabbit Anti Abca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti abca1/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit anti abca1 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Enhancement of growth inhibitory effect of NC on human renal carcinoma cells by co-treatment with an ABCA1 inhibitor cyclosporin A (CsA). Cells were grown with or without 20 μM NC and 10 μM CsA for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC. Results are shown as mean of at least four independent experiments ± SD (Tukey–Kramer’s multiple comparison test). n = 4 (KMRC-3,786-O,A498), 5 (Caki-1) or 6 (TUHR14TKB). ( B–E ) Immunoblot analysis of whole-cell lysate of human renal carcinoma cell lines. A representative result from three independent experiments is shown ( B ). Quantitative analyses of Snail ( C ) and ABCA1 ( D ) expression are presented. A scatter plot illustrating the correlation between ABCA1 and Snail expression levels is also shown ( E ). Quantitative data are shown as mean of three independent experiments ± SD (Tukey–Kramer’s test). ( F ) Comparison of ABCA1 expression between normal tissue and primary tumor of indicated subtypes of renal cancers analyzed using UCSC Xena ( https://xenabrowser.net/ ). Bars indicate means (Welch’s t- test). ( G ) Immunohistochemistry of a surgically extracted renal tissue from a patient with Fuhrman grade 3 primary ccRCC, indicating upregulation of ABCA1 in the lesion site. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissue . Scale bars, 250 μm (left), 50 μm (right). ( H ) Quantification of ABCA1 signal from surgically extracted renal tissues from three patients for each Fuhrman grade (Tukey–Kramer’s test; see also ). ( I ) Phase-contrast images of EpH4 wild-type cells (top) and Snail-overexpression cells (bottom, EpH4-Snail). Scale bars, 50 μm. ( J ) Immunofluorescence images of EpH4 and EpH4-Snail cells. The cells were fixed. Scale bars, 20 μm. ( K ) Acquisition of NC resistance by exogenous expression of Snail in EpH4 cells and enhancement of 20 μM NC effect on EpH4-Snail cells by co-treatment with 10 μM CsA. Data are presented as in ( A ) ( n = 3, Tukey–Kramer’s test). ( L ) Immunoblot analyses of whole-cell lysates of EpH4, EpH4-Snail, E-cadherin KO, and α-catenin KO EpH4 cells. Quantitative analyses of ABCA1 expression is also shown ( n = 3, Dunnett”s test). ( M ) Immunofluorescence images of EpH4 and EpH4-Snail cells. Cells were fixed with MeOH. Scale bars, 20 μm. ( N, O ) Immunoblot analyses of whole-cell lysates of MDCK II cells ( N ) expressing KRAS G12V treated with 5 μg/ml TGFβ for 0, 3, and 8 days and human esophageal carcinoma cell lines TE-15 and TE-8 ( O ). Graphs on the bottom show analyses from three biological replicates (Tukey–Kramer’s test [ N ] and Student’s t -test [ O ]). Phase-contrast images are also shown on the top ( O ). Scale bars, 50 μm. Figure 1—source data 1. Original raw data for the immunoblot images shown in . Figure 1—source data 2. Labeled full blot images for the immunoblot images shown in .

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A ) Enhancement of growth inhibitory effect of NC on human renal carcinoma cells by co-treatment with an ABCA1 inhibitor cyclosporin A (CsA). Cells were grown with or without 20 μM NC and 10 μM CsA for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC. Results are shown as mean of at least four independent experiments ± SD (Tukey–Kramer’s multiple comparison test). n = 4 (KMRC-3,786-O,A498), 5 (Caki-1) or 6 (TUHR14TKB). ( B–E ) Immunoblot analysis of whole-cell lysate of human renal carcinoma cell lines. A representative result from three independent experiments is shown ( B ). Quantitative analyses of Snail ( C ) and ABCA1 ( D ) expression are presented. A scatter plot illustrating the correlation between ABCA1 and Snail expression levels is also shown ( E ). Quantitative data are shown as mean of three independent experiments ± SD (Tukey–Kramer’s test). ( F ) Comparison of ABCA1 expression between normal tissue and primary tumor of indicated subtypes of renal cancers analyzed using UCSC Xena ( https://xenabrowser.net/ ). Bars indicate means (Welch’s t- test). ( G ) Immunohistochemistry of a surgically extracted renal tissue from a patient with Fuhrman grade 3 primary ccRCC, indicating upregulation of ABCA1 in the lesion site. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissue . Scale bars, 250 μm (left), 50 μm (right). ( H ) Quantification of ABCA1 signal from surgically extracted renal tissues from three patients for each Fuhrman grade (Tukey–Kramer’s test; see also ). ( I ) Phase-contrast images of EpH4 wild-type cells (top) and Snail-overexpression cells (bottom, EpH4-Snail). Scale bars, 50 μm. ( J ) Immunofluorescence images of EpH4 and EpH4-Snail cells. The cells were fixed. Scale bars, 20 μm. ( K ) Acquisition of NC resistance by exogenous expression of Snail in EpH4 cells and enhancement of 20 μM NC effect on EpH4-Snail cells by co-treatment with 10 μM CsA. Data are presented as in ( A ) ( n = 3, Tukey–Kramer’s test). ( L ) Immunoblot analyses of whole-cell lysates of EpH4, EpH4-Snail, E-cadherin KO, and α-catenin KO EpH4 cells. Quantitative analyses of ABCA1 expression is also shown ( n = 3, Dunnett”s test). ( M ) Immunofluorescence images of EpH4 and EpH4-Snail cells. Cells were fixed with MeOH. Scale bars, 20 μm. ( N, O ) Immunoblot analyses of whole-cell lysates of MDCK II cells ( N ) expressing KRAS G12V treated with 5 μg/ml TGFβ for 0, 3, and 8 days and human esophageal carcinoma cell lines TE-15 and TE-8 ( O ). Graphs on the bottom show analyses from three biological replicates (Tukey–Kramer’s test [ N ] and Student’s t -test [ O ]). Phase-contrast images are also shown on the top ( O ). Scale bars, 50 μm. Figure 1—source data 1. Original raw data for the immunoblot images shown in . Figure 1—source data 2. Labeled full blot images for the immunoblot images shown in .

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: CCK-8 Assay, Comparison, Western Blot, Expressing, Immunohistochemistry, Staining, Over Expression, Immunofluorescence, Labeling

    ( A–C ) Comparison of mRNA transcription of ABCA1 ( A, B ) and Snail ( C ) in different cancer types. Expression data from GDC TCGA database were analyzed using UCSC Xena platform ( https://xenabrowser.net/ ) (Welch’s t- test).

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A–C ) Comparison of mRNA transcription of ABCA1 ( A, B ) and Snail ( C ) in different cancer types. Expression data from GDC TCGA database were analyzed using UCSC Xena platform ( https://xenabrowser.net/ ) (Welch’s t- test).

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Comparison, Expressing

    Immunohistochemistry of surgically extracted renal tissues from patients with Fuhrman grade 13 primary ccRCC, indicating elevation of ABCA1 signal at the lesion site of higher-grade ccRCC. All samples were collected from independent patients. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissues . Scale bars, 100 μm.

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: Immunohistochemistry of surgically extracted renal tissues from patients with Fuhrman grade 13 primary ccRCC, indicating elevation of ABCA1 signal at the lesion site of higher-grade ccRCC. All samples were collected from independent patients. The ABCA1 staining was verified by the accumulation of known signals in renal tubules and glomeruli in normal tissues . Scale bars, 100 μm.

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Immunohistochemistry, Staining

    ( A ) Immunoblot analysis of whole-cell lysates of EpH4-Snail (without treatment) and EpH4 cells treated with inhibitors of PI3K-Akt pathway (5 μM GSK2334470: PDK1, 50 μM LY294002: PI3K, or 1 μM Wortmannin: PI3K for 24 h). Comparison of protein levels of ABCA1 and phospho-FoxO3a is also shown ( n =3, Tukey–Kramer’s test). ( B ) Immunoblot analysis of whole-cell lysates of EpH4 and EpH4-Snail cells ( n =3, Student’s t -test). Quantitative analysis of c-myc expression is also shown.

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A ) Immunoblot analysis of whole-cell lysates of EpH4-Snail (without treatment) and EpH4 cells treated with inhibitors of PI3K-Akt pathway (5 μM GSK2334470: PDK1, 50 μM LY294002: PI3K, or 1 μM Wortmannin: PI3K for 24 h). Comparison of protein levels of ABCA1 and phospho-FoxO3a is also shown ( n =3, Tukey–Kramer’s test). ( B ) Immunoblot analysis of whole-cell lysates of EpH4 and EpH4-Snail cells ( n =3, Student’s t -test). Quantitative analysis of c-myc expression is also shown.

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Western Blot, Comparison, Expressing

    ( A ) Immunoblot analysis of whole-cell lysates of wild-type and two lines of ABCA1 KO EpH4-Snail cells (#1 and #2). ( B ) Effect of ABCA1 knockout on growth inhibitory effect of nitidine chloride. Cells were grown with or without 20 μM NC for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC ( n =3, Tukey–Kramer’s test).

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A ) Immunoblot analysis of whole-cell lysates of wild-type and two lines of ABCA1 KO EpH4-Snail cells (#1 and #2). ( B ) Effect of ABCA1 knockout on growth inhibitory effect of nitidine chloride. Cells were grown with or without 20 μM NC for 24 h, and cell number was determined with CCK-8. Fold change in cell number by NC was shown as relative to controls without NC ( n =3, Tukey–Kramer’s test).

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Western Blot, Knock-Out, CCK-8 Assay

    ( A ) Comparison of sphingomyelin (SM) content relative to phospholipid content ( n =3, Student’s t -test). ( B ) Comparison of cholesterol (Chol)/SM ratio between EpH4 and EpH4-Snail cells ( n =3, Student’s t -test). ( C ) Fatty acid composition of SM determined using LC-MS. All peaks corresponding to d18:1-even fatty acid-SMs were included in the analysis and each peak value is expressed as a percentage. n.d., peak not detected ( n =3, Student’s t -test). ( D ) Pie charts of SM chain length profile from (C). SMs were classified into long-chain fatty acid (LCFA, orange) (≤20) and very long-chain fatty acid (VLCFA, purple) (>20) SMs. ( E ) Chain length specificity of Elovls and CerSs responsible for fatty acid profile of sphingolipids reported ( ; ). Elovls catalyze a rate-limiting step of fatty acid elongation cycle, and CerSs catalyze N- acylation of sphingoid bases to produce ceramides. ( F ) Comparison of transcription levels of Elovl s and CerS s. Notable decreases in expressions of Elovl7 and CerS3 in EpH4-Snail cells are indicated by asterisks. ( G ) Quantification of transcription levels of Elovl7 and CerS3 relative to that of ZO-1 , whose expression does not change between EpH4 and EpH4-Snail ( n =3, Student’s t -test). ( H ) Effect of supplementation of C22:0 ceramide (Cer22:0) on ABCA1 expression. EpH4-Snail cells were treated with 10 μM ceramide or 0.4% vehicle (dodecane/ethanol = 2/98) for 24 h, then whole-cell lysates were analyzed by immunoblot ( n =3, Student’s t -test). ( I ) Immunoblot analyses of whole-cell lysates of mouse epithelial (MTD-1A, CSG) and fibroblast (L-929, NIH3T3) cells. ( J ) Comparison of Chol/SM ratio of EpH4, EpH4-Snail, and normal fibroblasts ( n =3, Dunnett’s test). ( K ) Comparison of Chol/SM ratio between TE-15 and TE-8 ( n =3, Student’s t -test). ( L ) Scatter plot of Chol content against SM content used in (B), (H), and (I). Dashed lines indicate Chol/SM = 1.0 (blue) and 1.5 (red). The region of Chol/SM >1.5 is shown with red background. ( M ) Possible mechanism of induction of ABCA1 expression and lipid droplet enlargement through decrease in VLCFA-SM. In EpH4 (epithelial) cells, a certain amount of cholesterol is sequestered through interaction with SM, organizing ordered plasma membrane (PM). In EpH4-Snail (hybrid E/M) cells, the lower level of VLCFA-SM biosynthesis leads to a decrease in plasma membrane SM content, resulting in membrane disorder. The increase in SM-unbound form of cholesterol in PM induces its internalization and activation of cellular cholesterol sensors, resulting in lipid droplet enlargement and enhanced ABCA1 expression. Figure 3—source data 1. Original raw data for the RT-PCR and immunoblot images shown in . Figure 3—source data 2. Labeled uncropped gel and full blot images for the RT-PCR and immunoblot images shown in .

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A ) Comparison of sphingomyelin (SM) content relative to phospholipid content ( n =3, Student’s t -test). ( B ) Comparison of cholesterol (Chol)/SM ratio between EpH4 and EpH4-Snail cells ( n =3, Student’s t -test). ( C ) Fatty acid composition of SM determined using LC-MS. All peaks corresponding to d18:1-even fatty acid-SMs were included in the analysis and each peak value is expressed as a percentage. n.d., peak not detected ( n =3, Student’s t -test). ( D ) Pie charts of SM chain length profile from (C). SMs were classified into long-chain fatty acid (LCFA, orange) (≤20) and very long-chain fatty acid (VLCFA, purple) (>20) SMs. ( E ) Chain length specificity of Elovls and CerSs responsible for fatty acid profile of sphingolipids reported ( ; ). Elovls catalyze a rate-limiting step of fatty acid elongation cycle, and CerSs catalyze N- acylation of sphingoid bases to produce ceramides. ( F ) Comparison of transcription levels of Elovl s and CerS s. Notable decreases in expressions of Elovl7 and CerS3 in EpH4-Snail cells are indicated by asterisks. ( G ) Quantification of transcription levels of Elovl7 and CerS3 relative to that of ZO-1 , whose expression does not change between EpH4 and EpH4-Snail ( n =3, Student’s t -test). ( H ) Effect of supplementation of C22:0 ceramide (Cer22:0) on ABCA1 expression. EpH4-Snail cells were treated with 10 μM ceramide or 0.4% vehicle (dodecane/ethanol = 2/98) for 24 h, then whole-cell lysates were analyzed by immunoblot ( n =3, Student’s t -test). ( I ) Immunoblot analyses of whole-cell lysates of mouse epithelial (MTD-1A, CSG) and fibroblast (L-929, NIH3T3) cells. ( J ) Comparison of Chol/SM ratio of EpH4, EpH4-Snail, and normal fibroblasts ( n =3, Dunnett’s test). ( K ) Comparison of Chol/SM ratio between TE-15 and TE-8 ( n =3, Student’s t -test). ( L ) Scatter plot of Chol content against SM content used in (B), (H), and (I). Dashed lines indicate Chol/SM = 1.0 (blue) and 1.5 (red). The region of Chol/SM >1.5 is shown with red background. ( M ) Possible mechanism of induction of ABCA1 expression and lipid droplet enlargement through decrease in VLCFA-SM. In EpH4 (epithelial) cells, a certain amount of cholesterol is sequestered through interaction with SM, organizing ordered plasma membrane (PM). In EpH4-Snail (hybrid E/M) cells, the lower level of VLCFA-SM biosynthesis leads to a decrease in plasma membrane SM content, resulting in membrane disorder. The increase in SM-unbound form of cholesterol in PM induces its internalization and activation of cellular cholesterol sensors, resulting in lipid droplet enlargement and enhanced ABCA1 expression. Figure 3—source data 1. Original raw data for the RT-PCR and immunoblot images shown in . Figure 3—source data 2. Labeled uncropped gel and full blot images for the RT-PCR and immunoblot images shown in .

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Comparison, Liquid Chromatography with Mass Spectroscopy, Expressing, Western Blot, Clinical Proteomics, Membrane, Activation Assay, Reverse Transcription Polymerase Chain Reaction, Labeling

    ( A ) Schematic illustrating the molecular mechanisms for handling excess cholesterol to avoid cell death. Cells eliminate excess cholesterol through efflux mediated by transporters including ABCA1 or isolation into lipid droplets (LD) via esterification of cholesterol by acyl-CoA: cholesterol acyltransferases (ACATs) to avoid cell death. CsA and TMP-153 inhibit ABCA1 and ACATs, respectively. ( B ) Immunoblot analysis of whole-cell lysates of human kidney cell lines. Quantitative analysis of SOAT1 expression is also shown. ( C–F ), Effects of treatments with CsA ( C , E ) or TMP-153 ( D , F ) to cellular growth of EpH4 and EpH4-Snail ( C , D ) or human kidney cancer cell lines ( E , F ). Cells were treated with drugs for 24 h and relative cell number to 0.1% DMSO control was determined by CCK-8. Results are shown as mean of at least three independent experiments ± SD. ( G–I ) TMP-153 inhibits the growth of tumor xenografts composed of Snail-positive renal cancer 786-O cells. Experiments were performed as described in ‘Materials and methods’. In brief, 50 mg/kg TMP-153 was administered intraperitoneally to nude mice bearing 786-O tumor xenografts. After 21 days of the first administration, the overall appearance ( G ) and the excised tumors ( H ) of control and treated mice were compared. ( I ) Tumor growth curve in the xenograft model. Results are shown as mean of four biological replicates ± SD (Student’s t- test). Figure 4—source data 1. Original raw data for the immunoblot images shown in . Figure 4—source data 2. Labeled full blot images for the immunoblot images shown in .

    Journal: eLife

    Article Title: Chemotherapy resistance due to epithelial-to-mesenchymal transition is caused by abnormal lipid metabolic balance

    doi: 10.7554/eLife.104374

    Figure Lengend Snippet: ( A ) Schematic illustrating the molecular mechanisms for handling excess cholesterol to avoid cell death. Cells eliminate excess cholesterol through efflux mediated by transporters including ABCA1 or isolation into lipid droplets (LD) via esterification of cholesterol by acyl-CoA: cholesterol acyltransferases (ACATs) to avoid cell death. CsA and TMP-153 inhibit ABCA1 and ACATs, respectively. ( B ) Immunoblot analysis of whole-cell lysates of human kidney cell lines. Quantitative analysis of SOAT1 expression is also shown. ( C–F ), Effects of treatments with CsA ( C , E ) or TMP-153 ( D , F ) to cellular growth of EpH4 and EpH4-Snail ( C , D ) or human kidney cancer cell lines ( E , F ). Cells were treated with drugs for 24 h and relative cell number to 0.1% DMSO control was determined by CCK-8. Results are shown as mean of at least three independent experiments ± SD. ( G–I ) TMP-153 inhibits the growth of tumor xenografts composed of Snail-positive renal cancer 786-O cells. Experiments were performed as described in ‘Materials and methods’. In brief, 50 mg/kg TMP-153 was administered intraperitoneally to nude mice bearing 786-O tumor xenografts. After 21 days of the first administration, the overall appearance ( G ) and the excised tumors ( H ) of control and treated mice were compared. ( I ) Tumor growth curve in the xenograft model. Results are shown as mean of four biological replicates ± SD (Student’s t- test). Figure 4—source data 1. Original raw data for the immunoblot images shown in . Figure 4—source data 2. Labeled full blot images for the immunoblot images shown in .

    Article Snippet: The following primary antibodies were used for immunoblotting (IB), immunofluorescence microscopy (IF), and immunohistochemistry (IHC): rabbit anti-ABCA1 mAb (96292S, IB, IF), rabbit anti-Snail mAb (3879S, IB), rabbit anti-Akt mAb (4691S, IB), rabbit anti-phospho-Akt (T308) mAb (2965S, IB), and rabbit anti-phospho-FoxO3a (S253) pAb (9466S, IB) from Cell Signaling Technology; rabbit anti-ABCA1 pAb (NB400-105, IHC) from Novus Biologicals; rat anti-E-cadherin mAb (ECCD-2, IB, IF) from TaKaRa; mouse anti-cytokeratin 18 mAb (LS- C84878 , IF) from LS Bio; goat anti-LXR alpha + LXR beta pAb (ab24362, IF) from Abcam; and mouse anti-α-tubulin mAb (12G10, IB) produced in house.

    Techniques: Isolation, Western Blot, Expressing, Control, CCK-8 Assay, Labeling

    Treg exp increase ABCA1 expression by transferring cAMP into M IL4 . (A) Changes in the expression of ABCA1 and ABCG1 transcripts in M IL4 co-cultured with either Teffs or Treg exp . Gene expression quantified by qRT-PCR comparing mRNA levels in M IL4 alone (RQ = 1, shown as dashed line) with the same cells co-cultured for 4h with either Teffs or Tregs. UBC was used as reference gene. (B) Intracellular concentration of cAMP in Tregs exp alone, M IL4 alone, or M IL4 co-cultured with Tregs exp for 4h. cAMP levels were normalized to total cellular protein content. Statistical analysis was performed only between M IL4 and M IL4 + Tregs exp , as the aim was to assess whether cAMP levels in M IL4 increase upon co-culture. The cAMP level in Tregs exp is shown as a reference to highlight the high concentration of this molecule in these cells but was not included in the statistical comparison due to the difference in cell type. (C) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Treg exp (ratio 1:1) after 1h preincubation or not with GAP27 (300 µM). (D) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Tregs (ratio 1:1) after 1h preincubation or not with PKA inhibitor H89 (5 µM). (E) Western blot analysis of ABCA1 protein level in cell lysates of M IL4 alone or M IL4 co-cultured (ratio 1:1) with either Treg exp or Teff for 4h. Data were plotted as ABCA1 protein intensity normalised to GAPDH protein intensity. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison test. *p<0.05, **p<0.01.

    Journal: Frontiers in Immunology

    Article Title: Ex vivo expanded human regulatory T cells promote cholesterol efflux and PON1 expression in oxLDL-exposed macrophages via gap junction-mediated cAMP transfer

    doi: 10.3389/fimmu.2025.1662925

    Figure Lengend Snippet: Treg exp increase ABCA1 expression by transferring cAMP into M IL4 . (A) Changes in the expression of ABCA1 and ABCG1 transcripts in M IL4 co-cultured with either Teffs or Treg exp . Gene expression quantified by qRT-PCR comparing mRNA levels in M IL4 alone (RQ = 1, shown as dashed line) with the same cells co-cultured for 4h with either Teffs or Tregs. UBC was used as reference gene. (B) Intracellular concentration of cAMP in Tregs exp alone, M IL4 alone, or M IL4 co-cultured with Tregs exp for 4h. cAMP levels were normalized to total cellular protein content. Statistical analysis was performed only between M IL4 and M IL4 + Tregs exp , as the aim was to assess whether cAMP levels in M IL4 increase upon co-culture. The cAMP level in Tregs exp is shown as a reference to highlight the high concentration of this molecule in these cells but was not included in the statistical comparison due to the difference in cell type. (C) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Treg exp (ratio 1:1) after 1h preincubation or not with GAP27 (300 µM). (D) Changes in the expression of ABCA1 mRNA in M IL4 co-cultured with Tregs (ratio 1:1) after 1h preincubation or not with PKA inhibitor H89 (5 µM). (E) Western blot analysis of ABCA1 protein level in cell lysates of M IL4 alone or M IL4 co-cultured (ratio 1:1) with either Treg exp or Teff for 4h. Data were plotted as ABCA1 protein intensity normalised to GAPDH protein intensity. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison test. *p<0.05, **p<0.01.

    Article Snippet: Equal amounts of total protein were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to polyvinylidene difluoride (PVDF) membrane and probed overnight at 4C with the respective antibodies: monoclonal anti-ABCA1 antibody (CellSignaling; Cat Number 96292), polyclonal anti-PON1 antibody (Proteintech; Cat Number 18155-1-AP), monoclonal anti-GAPDH antibody (CellSignaling; Cat Number 5174), recombinant monoclonal anti-ABCA1 (phosho-S2054) antibody (Abcam; Cat Number ab125064).

    Techniques: Expressing, Transferring, Cell Culture, Gene Expression, Quantitative RT-PCR, Concentration Assay, Co-Culture Assay, Comparison, Western Blot